IP Library Granted Patent US 10,239,262
Granted Patent B2
US 10,239,262 · App. 13/677,644 · Granted Mar 26, 2019

Fiber scaffolds for use in tracheal prostheses

Inventor: Jed K. Johnson (London, OH)
Assignee: NANOFIBER SOLUTIONS, LLC
B29C67/0051A61F2/04A61F2/20A61L27/3612A61L27/3882A61L27/40B29C64/00A61F2002/043A61F2002/046A61F2240/005A61L2430/22B29K2067/003B29K2075/00B29K2311/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,239,262
App. No.
13/677,644
Granted
Mar 26, 2019
Kind
B2
Abstract

A synthetic organ suitable for transplantation into a biological organism is provided. This synthetic organ includes a three-dimensional polymer scaffold, wherein the shape and dimensions of the polymer scaffold are based on a native organ, wherein the polymer scaffold further includes at least one layer of polymer fibers that have been deposited by electrospinning, and wherein the orientation of the fibers in the scaffold relative to one another is generally parallel, random, or both; and wherein the polymer scaffold has been preseeded with at least one type of biological cell prior to implantation into a biological organism, and wherein the at least one type of biological cell is operative to facilitate integration of the polymer scaffold into the organism so that the polymer scaffold may function in a manner significantly similar to or the same as the native organ.

Claims (19)

1. A synthetic organ comprising:

a scaffold comprising at least one polymeric electrospun fiber and a plurality of porous synthetic cartilage rings, the scaffold having a shape based on a native human trachea; and

at least one type of biological cell selected from the group consisting of autologous cells, allogeneic cells, cord blood cells, embryonic stem cells, induced pluripotent cells, mesenchymal cells, placental cells, bone marrow derived cells, hematopoietic cells, epithelial cells, endothelial cells, fibroblasts and chondrocytes;

wherein the porous synthetic cartilage rings consist of polyurethane; and

wherein the porous synthetic cartilage rings have a pore diameter of about 10 μm to about 30 μm.

2. The synthetic organ of claim 1 , further comprising a compound selected from the group consisting of proteins, peptides, and combinations thereof.

3. The synthetic organ of claim 1 , further comprising a selectively dissolvable particle.

4. The synthetic organ of claim 1 , wherein the at least one polymeric electrospun fiber comprises a non-resorbable material selected from the group consisting of polyethylene terephthalate, silicone, polyurethane, polycarbonate, polyether ketone, and combinations thereof.

5. The synthetic organ of claim 1 , wherein the at least one polymeric electrospun fiber comprises a resorbable material selected from the group consisting of polycaprolactone (PCL), polylactic acid (PLA), polyglycolic acid (PGA), and combinations thereof.

6. The synthetic organ of claim 1 , wherein the at least one polymeric electrospun fiber comprises a predetermined ratio of one or more polymers selected from the group consisting of polyethylene terephthalate (PET), polyetherketoneketone (PEKK), polyurethane (PU), polycarbonate (PC), polyamide (Nylon), and combinations thereof.

7. The synthetic organ of claim 1 , wherein the at least one polymeric electrospun fiber comprises a natural polymer selected from the group consisting of collagen, gelatin, fibronectin, hyaluronic acid, and combinations thereof.

8. The synthetic organ of claim 1 , further comprising an additive selected from the group consisting of fluorescence compounds, radio opaque compounds, anti-bacterial compounds, growth hormones, conductive compounds, ceramic compounds, metallic compounds, oxygen sensing compounds, radioactive compounds, cell growth promoting compounds, proteins, hormones, cytokines, and combinations thereof.

9. The synthetic organ of claim 1 , wherein the at least one polymeric electrospun fiber has a diameter of about 250 nm and a pore size of about 3-5 μm.

10. The synthetic organ of claim 1 , wherein the at least one polymeric electrospun fiber further comprises pores, dimples, hairs, or combinations thereof.

11. The synthetic organ of claim 1 , wherein the at least one polymeric electrospun fiber comprises a blend of polyethylene terephthalate and polyurethane.

12. The synthetic organ of claim 1 , wherein the at least one polymeric electrospun fiber comprises polyethylene terephthalate fibers and polyurethane fibers.

13. The synthetic organ of claim 1 , wherein the at least one polymeric electrospun fiber has a diameter of about 1 μm and a pore size of about 7-10 μm.

14. The synthetic organ of claim 1 , wherein the at least one polymeric electrospun fiber has a diameter of about 10 μm and a pore size of about 50-70 μm.

15. The synthetic organ of claim 1 , wherein the at least one polymeric electrospun fiber comprises 50 wt % polyethylene terephthalate and 50 wt % polyurethane.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2022
From: NANOFIBER SOLUTIONS, LLC
To: NFS IP HOLDINGS, LLC
Reel/Frame 061882/0663 →
CHANGE OF NAME Recorded Mar 21, 2019
From: NANOFIBER SOLUTIONS, INC.
To: NANOFIBER SOLUTIONS, LLC
Reel/Frame 048680/0973 →
CHANGE OF NAME Recorded Jan 22, 2019
From: NANOFIBER SOLUTIONS, INC
To: NANOFIBER SOLUTIONS, LLC
Reel/Frame 048105/0952 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2015
From: JOHNSON, JED K.
To: NANOFIBER SOLUTIONS, INC.
Reel/Frame 034765/0826 →
Continuity (4)
Provisional Application 61562090 · Nov 21, 2011
Provisional Application 13385612 · Feb 9, 2012
Provisional Application 61660048 · Jun 15, 2012
Related Publication 20130150963A1 · Jun 13, 2013
Cited By (5)
US 12,201,749 US 12,246,114 US 12,263,269 US 12,491,061 US 12,564,658